JUST IN: KEMRI, Tonix Pharmaceuticals partner to conduct Phase I clinical trial for TNX-801, an mpox vaccine 

  The partnership deal will see Tonix Pharmaceuticals, a fully-integrated biopharmaceutical company, design and conduct a Phase I clinical trial of the vaccine designed to prevent Mpox. Read More